171 related articles for article (PubMed ID: 31556787)
1. Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression.
Ahmadimanesh M; Abbaszadegan MR; Morshedi Rad D; Moallem SA; Mohammadpour AH; Ghahremani MH; Farid Hosseini F; Behdani F; Akhondpour Manteghi A; Jowsey P; Shabani Behbahani F; Moallem SMH; Etemad L
J Psychopharmacol; 2019 Nov; 33(11):1364-1376. PubMed ID: 31556787
[TBL] [Abstract][Full Text] [Related]
2. Oxidative DNA damage and reduced expression of DNA repair genes: Role in primary open angle glaucoma (POAG).
Mohanty K; Dada R; Dada T
Ophthalmic Genet; 2017; 38(5):446-450. PubMed ID: 28129013
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of PARP1 transcription by CDK4/6 inhibitors sensitizes human lung cancer cells to anticancer drug-induced death by impairing OGG1-dependent base excision repair.
Tempka D; Tokarz P; Chmielewska K; Kluska M; Pietrzak J; Rygielska Ż; Virág L; Robaszkiewicz A
Redox Biol; 2018 May; 15():316-326. PubMed ID: 29306194
[TBL] [Abstract][Full Text] [Related]
4. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
Miner CM; Brown EB; Gonzales JS; Munir R
J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
[TBL] [Abstract][Full Text] [Related]
5. PARP1 and OGG1 in Medicated Patients With Depression and the Response to ECT.
Ryan KM; McLoughlin DM
Int J Neuropsychopharmacol; 2023 Feb; 26(2):107-115. PubMed ID: 36472850
[TBL] [Abstract][Full Text] [Related]
6. Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
Leggio GM; Micale V; Drago F
Eur Neuropsychopharmacol; 2008 Apr; 18(4):271-7. PubMed ID: 17804207
[TBL] [Abstract][Full Text] [Related]
7. Oxidative DNA damage and its repair in rat spleen following subchronic exposure to aniline.
Ma H; Wang J; Abdel-Rahman SZ; Boor PJ; Khan MF
Toxicol Appl Pharmacol; 2008 Dec; 233(2):247-53. PubMed ID: 18793663
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison.
Matreja PS; Badyal DK; Khosla P; Deswal RS
Hum Psychopharmacol; 2007 Oct; 22(7):477-82. PubMed ID: 17647298
[TBL] [Abstract][Full Text] [Related]
9. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
Mullins CD; Shaya FT; Meng F; Wang J; Harrison D
Pharmacotherapy; 2005 May; 25(5):660-7. PubMed ID: 15899727
[TBL] [Abstract][Full Text] [Related]
10. Alterations in levels of 8-Oxo-2'-deoxyguanosine and 8-Oxoguanine DNA glycosylase 1 during a current episode and after remission in unipolar and bipolar depression.
Ceylan D; Yılmaz S; Tuna G; Kant M; Er A; Ildız A; Verim B; Akış M; Akan P; İşlekel H; Veldic M; Frye M; Özerdem A
Psychoneuroendocrinology; 2020 Apr; 114():104600. PubMed ID: 32062372
[TBL] [Abstract][Full Text] [Related]
11. Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.
Voineskos AN; Wilson AA; Boovariwala A; Sagrati S; Houle S; Rusjan P; Sokolov S; Spencer EP; Ginovart N; Meyer JH
Psychopharmacology (Berl); 2007 Sep; 193(4):539-45. PubMed ID: 17497139
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
Redrobe JP; Bourin M
Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290
[TBL] [Abstract][Full Text] [Related]
13. Is left stroke a risk-factor for selective serotonin reuptake inhibitor antidepressant treatment resistance?
Spalletta G; Guida G; Caltagirone C
J Neurol; 2003 Apr; 250(4):449-55. PubMed ID: 12700911
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
15. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
[TBL] [Abstract][Full Text] [Related]
16. DNA repair gene OGG1 polymorphism and its relation with oxidative DNA damage in patients with Alzheimer's disease.
Dinçer Y; Akkaya Ç; Mutlu T; Yavuzer S; Erkol G; Bozluolcay M; Guven M
Neurosci Lett; 2019 Sep; 709():134362. PubMed ID: 31299287
[TBL] [Abstract][Full Text] [Related]
17. Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis.
Hieronymus F; Lisinski A; Nilsson S; Eriksson E
Lancet Psychiatry; 2019 Sep; 6(9):745-752. PubMed ID: 31303567
[TBL] [Abstract][Full Text] [Related]
18. OGG1 DNA Repair Gene Polymorphism As a Biomarker of Oxidative and Genotoxic DNA Damage.
Miglani K; Kumar S; Yadav A; Aggarwal N; Gupta R
Iran Biomed J; 2021 Jan; 25(1):47-53. PubMed ID: 33129239
[TBL] [Abstract][Full Text] [Related]
19. Forced titration as a confound in an SSRI comparator study of sertaline versus citalopram in the treatment of major depressive disorder.
Burt T; Lane RM
Biol Psychiatry; 2001 Jul; 50(1):66-8. PubMed ID: 11478291
[No Abstract] [Full Text] [Related]
20. Alzheimer's disease-associated polymorphisms in human OGG1 alter catalytic activity and sensitize cells to DNA damage.
Jacob KD; Noren Hooten N; Tadokoro T; Lohani A; Barnes J; Evans MK
Free Radic Biol Med; 2013 Oct; 63():115-25. PubMed ID: 23684897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
